Liu SY, Trope GE, Buys YM, El-Defrawy SR, Khan AM, Jin YP. Visual impairment and the Ontario disability support program. Can J Ophthalmol. 2020 Jun;55(3):212-20. doi: 10.1016/j.jcjo.2019.12.009
Ara R, Basarir H, Ward SE. Principles of health economic evaluations of lipid-lowering strategies. Curr Opin Lipidology. 2012 Aug;23(4):271-81. doi: 10.1097/MOL.0b013e32835423d9
Hauber B, Candrilli S, Snyder EH, McBurney CR. Validation of a model to assess long-term disease progression in Alzheimer's disease patients treated with rivastigmine. Neurobiol Aging. 2004 Jan 1;25:S136.
Vitolins MZ, Anthony M, Burke GL. Soy protein isoflavones, lipids and arterial disease. Curr Opin Lipidology. 2001 Aug;12(4):433-7.